Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.
- DOI
- 10.1186/s12885-019-5687-0
- Published
- 2019-05-30
- Container
- BMC Cancer
- Publisher
- Figshare
- Open access
- yes
Credibility signals
uncertain Score 61/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0. Presence improves reuse transparency, not research validity.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-019-5687-0,
title = {Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.},
author = {Perez EA and de Haas SL and Eiermann W and Barrios CH and Toi M and Im YH and Conte PF and Martin M and Pienkowski T and Pivot XB and Burris HA and Stanzel S and Patre M and Ellis PA.},
year = {2019},
journal = {BMC Cancer},
doi = {10.1186/s12885-019-5687-0},
url = {https://doi.org/10.1186/s12885-019-5687-0}
}RIS
TY - JOUR TI - Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer. AU - Perez EA AU - de Haas SL AU - Eiermann W AU - Barrios CH AU - Toi M AU - Im YH AU - Conte PF AU - Martin M AU - Pienkowski T AU - Pivot XB AU - Burris HA AU - Stanzel S AU - Patre M AU - Ellis PA. PY - 2019 JO - BMC Cancer DO - 10.1186/s12885-019-5687-0 UR - https://doi.org/10.1186/s12885-019-5687-0 ER -
APA
EA, P., SL, D. H., W, E., CH, B., M, T., YH, I., PF, C., M, M., T, P., XB, P., HA, B., S, S., M, P., & PA., E. (2019). Relationship between tumor biomarkers and efficacy in MARIANNE, a phase III study of trastuzumab emtansine ± pertuzumab versus trastuzumab plus taxane in HER2-positive advanced breast cancer.. BMC Cancer. https://doi.org/10.1186/s12885-019-5687-0
Source records
- europe-pmc · retrieved 2026-09-27T06:00:31.166Z
- datacite · retrieved 2026-09-27T06:00:31.154Z
- datacite · retrieved 2026-09-27T06:00:31.154Z
- doaj · retrieved 2026-09-27T06:00:31.290Z